9岁时,不同培养基进行胚胎培养的辅助生殖技术儿童的甲基化组在全基因组范围内无显著差异
本研究随访了先前伪随机分配至G3或K-SICM培养基进行胚胎培养的辅助生殖技术(ART)儿童,在9岁时采集唾液分析甲基化组。共纳入120例单胎(G3组65例,K-SICM组55例),最终106例样本(G3组57例,K-SICM组49例)和659708个位点纳入分析。校正多重检验后,未发现两组间任何CpG位点、基因、启动子或CpG岛存在显著差异甲基化,尽管采用了宽松的校正P值阈值0.1;印记基因和出生体重相关位点的靶向分析亦无显著差异。
要点
- 校正多重检验后,G3与K-SICM培养基组儿童在全基因组CpG位点、基因、启动子和CpG岛均未发现显著差异甲基化。
- 印记基因和出生体重相关位点的靶向分析也未发现两组间显著差异。
- iEVORA识别出101个差异变异CpG位点,其中94个在G3组变异更大。
核心结论
- 研究结果令人安心,提示若培养基对DNA甲基化(及甲基化介导的疾病风险)存在影响,本研究所比较的两种培养基之间并无差异。
研究设计与样本
- 本研究为先前培养基比较研究的随访,夫妇被伪随机分配至G3或K-SICM培养基进行胚胎培养。
- 共招募120例9岁单胎儿童(G3组65例,K-SICM组55例),采集唾液样本。
- 使用Infinium MethylationEPIC芯片分析甲基化组,经质量和上下文过滤后保留106例样本(G3组57例,K-SICM组49例)和659708个位点进行分析。
- 差异甲基化分析采用混合效应线性模型,校正年龄、性别、样本板和细胞组成。
主要发现
- 校正多重检验后,即使采用宽松的校正P值阈值0.1,G3组与K-SICM组之间也未发现显著差异甲基化的CpG位点、基因、启动子或CpG岛。
- 对印记基因(内位点)和出生体重相关位点的靶向分析也未发现显著差异。
- 每例样本的DNA甲基化离群值数量在培养基组间相当。
- iEVORA识别出101个差异变异CpG位点,其中94个在G3组变异更大。
临床怎么用
- 原文未据此给出推荐。
局限性
- 要检测组间小于10%的显著甲基化差异,需要远多于此的参与者;然而如此小差异的临床相关性尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can we detect DNA methylation differences between ART children that underwent embryo culture in different media? SUMMARY ANSWER: We identified no significant differences in site-specific or regional DNA methylation between the different culture medium groups. WHAT IS KNOWN ALREADY: Embryo culture in G3 or K-SICM medium leads to differences in embryonic, neonatal and childhood outcomes, including growth and weight. The methylome may mediate this association as the period of in vitro culture of ART treatments coincides with epigenetic reprogramming. STUDY DESIGN, SIZE, DURATION: This study was conducted as a follow-up to a previous culture medium comparison study in which couples were pseudo-randomized to embryo culture in G3 or K-SICM medium. Of the resultant singletons, 120 (n = 65 G3, n = 55 K-SICM), were recruited at age 9. PARTICIPANTS/MATERIALS, SETTING, METHODS: The ART children provided a saliva sample from which the methylome was analysed using the Infinium MethylationEPIC array. After quality and context filtering, 106 (n = 57 G3, n = 49 K-SICM) samples and 659 708 sites were retained for the analyses. Differential methylation analyses were conducted using mixed effects linear models corrected for age, sex, sample plate and cell composition. These were applied to all cytosine-guanine dinucleotide (CpG) sites, various genomic regions (genes, promoters, CpG Islands (CGIs)) and as a targeted analysis of imprinted genes and birth weight-associated CpG sites. Differential variance was assessed using the improved epigenetic variable outliers for risk prediction analysis (iEVORA) algorithm and methylation outliers were identified using a previously defined threshold (upper or lower quartile plus or minus three times the interquartile range, respectively). MAIN RESULTS AND THE ROLE OF CHANCE: After correcting for multiple testing, we did not identify any significantly differentially methylated CpG sites, genes, promoters or CGIs between G3 and K-SICM children despite a lenient corrected P-value threshold of 0.1. Targeted analyses of (sites within) imprinted genes and birth weight-associated sites also did not identify any significant differences. The number of DNA methylation outliers per sample was comparable between the culture medium groups. iEVORA identified 101 differentially variable CpG sites of which 94 were more variable in the G3 group. LARGE SCALE DATA: Gene Expression Omnibus (GEO) GSE196432. LIMITATIONS, REASONS FOR CAUTION: To detect significant methylation differences with a magnitude of <10% between the groups many more participants would be necessary; however, the clinical relevance of such small differences is unclear. WIDER IMPLICATIONS OF THE FINDINGS: The results of this study are reassuring, suggesting that if there is an effect of the culture medium on DNA methylation (and methylation-mediated diseases risk), it does not differ between the two media investigated here. The findings concur with other methylome studies of ART neonates and children that underwent embryo culture in different media, which also found no significant methylome differences. STUDY FUNDING/COMPETING INTEREST(S): Study funded by March of Dimes (6-FY13-153), EVA (Erfelijkheid Voortplanting & Aanleg) specialty programme (grant no. KP111513) of Maastricht University Medical Centre (MUMC+) and the Horizon 2020 innovation (ERIN) (grant no. EU952516) of the European Commission. The authors do not report any conflicts of interest relevant to this study. TRIAL REGISTRATION NUMBER: Dutch Trial register-NL4083.
引用
- Koeck RM, Busato F, Tost J, et al. At age 9, the methylome of assisted reproductive technology children that underwent embryo culture in different media is not significantly different on a genome-wide scale. Hum Reprod. 2022. PMID: 36206092. doi:10.1093/humrep/deac213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。